Nosocomial Pneumonia: Clinical Trials

21 trials for Nosocomial Pneumonia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed, 3 unknown, 1 active not recruiting, 1 not yet recruiting. 6 Not applicable, 4 Phase 3, 3 Phase 2, 1 Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable6Completed 3, Active not recruiting 1, Not yet recruiting 1, Recruiting 1
Phase 34Completed 2, Unknown 2
Phase 23Unknown 2, Terminated 1
Phase 11Completed 1
Phase 41Completed 1

Follow Nosocomial Pneumonia: new trials by email Literature Review of Nosocomial Pneumonia trials Research Report on Nosocomial Pneumonia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Mechanical Insufflation-exsufflation and Hypertonic Saline in Nosocomial Bacterial Respiratory Tract Infection
Mechanical insufflation-exsufflation, Standard of Care, Hypertonic saline with hyaluronic acid - Nosocomial Infection, Nosocomial Pneumonia
Not applicableNot yet recruitingHospital San Carlos, Madrid1002026-01-012025-03-26
Role of Oral Care in Prevention of Nosocomial Pneumonia Among COPD Patients
Oral care - Nosocomial Pneumonia, COPD Exacerbation
Not applicableRecruitingAssiut University602024-10-012024-11-15
High-dose Inhaled NO Therapy for the pREvenvention of NP After Cardiac Surgery Under CPB
Sham treatment, 200-ppm NO - Nosocomial Pneumonia
Not applicableCompletedTomsk National Research Medical Center of the Russian Academy of Sciences1602024-02-202026-06-24
High-dose Inhalations of Nitric Oxide in the Treatment of Pneumonia
200 ppm Nitric Oxide, Sham treatment - Nosocomial Pneumonia, Community-acquired Pneumonia
Not applicableActive not recruitingTomsk National Research Medical Center of the Russian Academy of Sciences2002024-01-152026-07-30
High-dose Inhaled NO Therapy for the Prevention of Nosocomial Pneumonia After Cardiac Surgery With CPB
Sham treatment, 200- ppm NO - Nosocomial Pneumonia
Not applicableCompletedTomsk National Research Medical Center of the Russian Academy of Sciences742023-11-172026-06-26
Pathogens Involved in Secondary Infections During Severe Forms of Covid-19 Pneumonia:
Covid19, Ventilator Associated Pneumonia
UnknownFondation Hôpital Saint-Joseph222020-09-112023-03-07
Safety and Pharmacokinetics of Ceftolozane/Tazobactam in Pediatric Participants With Nosocomial Pneumonia (MK-7625A-036)
Ceftolozane/Tazobactam - Nosocomial Pneumonia
Phase 1CompletedMerck Sharp & Dohme LLC412020-04-172025-09-22
The Role of Point-of-care Polymerase Chain Reaction in Managing Nosocomial Pneumonia
no intervention - Nosocomial Pneumonia
CompletedIuliu Hatieganu University of Medicine and Pharmacy602017-02-012023-07-03
International Study on NoSocomial Pneumonia in Intensive CaRE (PneumoINSPIRE)
No intervention - Nosocomial Pneumonia
CompletedThe University of Queensland16572016-02-012021-05-03
SEPREVEN: a Stepped-wedge Randomised Controlled Trial
Education program for NICU caregivers - Intensive Care Units, Neonatal, Misadventures to Patients During Surgical and Medical Care
Not applicableCompletedDr Caeymaex Laurence80002015-11-232020-12-29
Advanced Understanding of Staphylococcus Aureus and Pseudomonas Aeruginosa Infections in EuRopE - ICU
Various observed exposure(s) of interest - Pneumonia, Pneumonia, Ventilator-Associated
CompletedJan Kluytmans20312015-04-012019-05-08
Use of Microscopy, Cultures and Molecular Biological Methods for Diagnosing Nosocomial Pneumonia
Microbiological diagnostics on pulmonary secretion - Nosocomial Pneumonia
CompletedZealand University Hospital222014-05-012021-04-22
Effect of Antioxidant Vitamins on Coagulopathy and Nosocomial Pneumonia After Severe Trauma
Vitamin C, Vitamin E, Saline (for Vitamin C) - Coagulopathy, Nosocomial Pneumonia
Phase 2TerminatedUniversity of Alabama at Birmingham112013-05-012017-03-29
Characteristics of Lower Respiratory Tract Escherichia Coli Isolates in Mechanically Ventilated Intensive Care Patients
Nosocomial Pneumonia, Ventilator Associated Pneumonia
CompletedHôpital Louis Mourier2892012-03-272017-10-06
Optimizing Dosing Regimen of Piperacillin/Tazobactam for Nosocomial Pneumonia
C Group, E Group - Nosocomial Pneumonia
Phase 2 / Phase 3UnknownTianjin Medical University Cancer Institute and Hospital502012-03-012016-02-17
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care: - Adenovirus, Anesthesia
CompletedDaniel Benjamin35202011-11-012023-09-06
Cost Study of Linezolid Versus Vancomycin Among Previously Hospitalized Patients
Linezolid, Vancomycin - Complicated Skin and Structure Infection, Nosocomial Pneumonia
CompletedPfizer72602011-05-012012-05-22
Oral Hygiene With Chlorhexidine and Incidence of Ventilator-Associated Pneumonia in Children Submitted to Heart Surgery
oral hygiene, placebo - Ventilator Associated Pneumonia, Nosocomial Pneumonia
Phase 3CompletedUniversity of Sao Paulo1602006-02-012009-01-27
Effectiveness of Dental Brushing for Preventing Ventilator-Associated Pneumonia
Toothbrushing - Ventilator-Associated Pneumonia, Nosocomial Pneumonia
Phase 2 / Phase 3UnknownHospital Universitari Joan XXIII de Tarragona.4002005-05-012009-02-12
Effect of Oral Decontamination Using Chlorhexidine or Potassium Permanganate in ICU Patients
Chlorhexidine gluconate, Potassium permanganate - Nosocomial Pneumonia, Healthcare-Associated Pneumonia
Phase 4CompletedKing Edward Memorial Hospital5122004-05-012008-02-07

Showing 20 of 21. Sign in to see all of them.

Narrower conditions

Healthcare-Associated Pneumonia (21)  ·  Pneumonia, Ventilator-Associated (8)  ·  Pneumonia (5)  ·  Staphylococcal Infections (2)  ·  Adenoviridae Infections (1)  ·  Anxiety Disorders (1)  ·  Arrhythmias, Cardiac (1)  ·  Autistic Disorder (1)  ·  Bipolar Disorder (1)  ·  Bradycardia (1)  ·  COVID-19 (1)  ·  Central Nervous System Infections (1)  ·  Community-Acquired Pneumonia (1)  ·  Coronavirus Infections (1)  ·  Critical Illness (1)

Broader conditions

Disease Attributes (21)  ·  Iatrogenic Disease (21)  ·  Pathologic Processes (21)  ·  Pathological Conditions, Signs and Symptoms (21)  ·  Respiratory Tract Infections (21)  ·  Cross Infection (20)  ·  Infections (20)  ·  Lung Diseases (20)  ·  Respiratory Tract Diseases (20)  ·  Pneumonia (16)  ·  Bacterial Infections (3)  ·  Bacterial Infections and Mycoses (3)  ·  Cardiovascular Diseases (2)  ·  Chronic Disease (2)  ·  Gram-Positive Bacterial Infections (2)

Interventions

Nitric Oxide (3)  ·  Vancomycin (2)  ·  Alfentanil (1)  ·  Amikacin (1)  ·  Aminocaproic Acid (1)  ·  Ascorbic Acid (1)  ·  Bosentan (1)  ·  Cefepime (1)  ·  Cidofovir (1)  ·  Ciprofloxacin (1)  ·  Clozapine (1)  ·  Dental Care Team (1)  ·  Fosfomycin (1)  ·  Haloperidol (1)  ·  Hyaluronic Acid (1)

Sponsors

Tomsk National Research Medical Center of the Russian Academy of Sciences (3)  ·  Assiut University (1)  ·  Daniel Benjamin (1)  ·  Dr Caeymaex Laurence (1)  ·  Fondation Hôpital Saint-Joseph (1)  ·  Hospital San Carlos, Madrid (1)  ·  Hospital Universitari Joan XXIII de Tarragona. (1)  ·  Hôpital Louis Mourier (1)  ·  Iuliu Hatieganu University of Medicine and Pharmacy (1)  ·  Jan Kluytmans (1)  ·  Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (1)  ·  King Edward Memorial Hospital (1)  ·  Merck Sharp & Dohme LLC (1)  ·  Pfizer (1)  ·  The University of Queensland (1)

Countries

Russia (4)  ·  Spain (3)  ·  United States (3)  ·  France (2)  ·  Greece (2)  ·  Australia (1)  ·  Canada (1)  ·  Chile (1)  ·  China (1)  ·  Colombia (1)  ·  Denmark (1)  ·  Egypt (1)  ·  Estonia (1)  ·  India (1)  ·  Israel (1)

Top investigators

Nikolay O. Kamenshchikov (2)  ·  Andrei Balan, MD (1)  ·  Chi Hornik, PharmD (1)  ·  Despoina Koulenti, MD,PhD (1)  ·  Dilip R Karnad, MD,FACP,FRCP (1)  ·  Jean-Damien Ricard, MD, PhD (1)  ·  Jean-Francois Pittet, M.D. (1)  ·  Jeffrey Kerby, M.D., Ph.D. (1)  ·  Jeffrey Lipman, MBBCh, MD (1)  ·  Jordi Rello, MD, PhD (1)

Results publications

PMID 12749509, PMID 19482956, PMID 21558772, PMID 24614374, PMID 24949994, PMID 26039810, PMID 26926644, PMID 27522443, PMID 28137820, PMID 28290120, PMID 28779462, PMID 28946849, PMID 29084742, PMID 29271816, PMID 29435949, PMID 29677389, PMID 30790601, PMID 31317556, PMID 31548185, PMID 31814149, PMID 32324313, PMID 32497307, PMID 32756081, PMID 33029806, PMID 33903114, PMID 34245272, PMID 34302290, PMID 35065786, PMID 35370711, PMID 35491971, PMID 36918264, PMID 37325351, PMID 37415223, PMID 38046390, PMID 38307525, PMID 38636983, PMID 41247430

NIH funding

2018 (1)